Limiting the level of tertiary amines on polyamines leads to biocompatible nucleic acid vectors. (2017)

First Author: Simão Carlos MI
Attributed to:  Technologies for the Treatment of Brain Diseases funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ijpharm.2017.04.059

PubMed Identifier: 28450169

Publication URI: http://europepmc.org/abstract/MED/28450169

Type: Journal Article/Review

Volume: 526

Parent Publication: International journal of pharmaceutics

Issue: 1-2

ISSN: 0378-5173